APOE and Alzheimer disease: The prior study indicated that the APOE ε4 carriers had significant decreases in cerebral metabolic rate for glucose (CMRgl) in cingulate cortex and parahippocampal, which was associated with the predisposition to Alzheimer’s dementia [46].